Reformulating rofecoxib: targeted nanostructured lipid carrier gel for localized treatment of rheumatoid arthritis
ROX-NLCs gel provides a safe, sustained, and effective topical delivery system for RA therapy, enhancing local efficacy while reducing systemic cardiotoxic risk.
Authors
- Tulshidas S. Patil (ORCID: https://orcid.org/0000-0003-3323-6637)
- Kiran Balasaheb Aher (ORCID: https://orcid.org/0000-0002-6719-0553)
- Abhijeet A. Aher (ORCID: https://orcid.org/0000-0002-5287-3001)
- Sanket Gangurde
- Nayan A. Gujarathi
Institutions
- Narsee Monjee Institute of Management Studies (IN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1080/03639045.2026.2615166
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00